Description
A RARɣ agonist (EC50 = 30 nM in a transactivation assay); selective for RARɣ over RARβ (EC50 = 1,000 nM in the same assay); decreases long bone growth and digit formation of isolated mouse embryonic limb buds in vitro at 0.01 and 0.1 µM; increases the skin expression of retinoid metabolism-related genes, including Rdh10, Crabp2, and Krt4, as well as epidermal barrier genes, including Spink5, Klk5, and Klk7 when applied topically to mice at 40 nmol
Formal name: 3-fluoro-4-[[2-hydroxy-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)acetyl]amino]benzoic acid
Synonyms: BMS 961
Molecular weight: 399.5
CAS: 185629-22-5
Purity: ≥98%
Formulation: A crystalline solid